IE 11 is a very old Browser and it`s not supported on this site

2. Details and explanations to the financial statements 

2.1 Other current liabilities

The other current liabilities comprise the following (in CHF):

 

 

2020

 

2019

Third parties

 

308 546

 

303 770

Investment Manager

 

72 644

 

100 839

 

 

381 190

 

404 609

2.2 Shareholders’ equity

The share capital of the Company consists of 55.4 mn fully paid registered shares (2019: 55.4 mn registered shares) with a par value of CHF 0.20 each (2019: CHF 0.20).

The General Shareholders’ Meeting held on March 17, 2016, has approved a share buy-back program, whereby up to 5 540 000 shares may be repurchased by the Company. Until the end of the program, at April 11, 2019, no shares had been repurchased under this share buy-back program.

The Board of Directors has approved the repurchase of a maximum of 5 540 000 own registered shares with a nominal value of CHF 0.20 each. The share buy-back program will run from April 12, 2019, until April 11, 2022, at the latest. Until December 31, 2020, no shares had been repurchased under this share buy-back program. A repurchase would take place via second trading line for the purpose of a subsequent capital reduction.

At December 31, 2020 and 2019, the Company has neither authorized nor conditional capital.

2.3 Other income

Other income comprises the following (in CHF):

 

 

2020

 

2019

Income group services

 

5 500 500

 

6 101 000

Other income

 

3 045

 

9 185

 

 

5 503 545

 

6 110 185

2.4 Administrative expenses

Administrative expenses comprise the following (in CHF):

 

 

2020

 

2019

Board compensation

 

1 272 316

 

1 151 684

Investment manager compensation

 

723 837

 

737 585

Staff costs

 

81 669

 

85 164

 

 

2 077 822

 

1 974 433

The remuneration report discloses further details to the Board of Directors compensation.

2.5 Other expenses

Other expenses comprise the following (in CHF):

 

 

2020

 

2019

Marketing and financial reporting

 

1 612 762

 

1 872 325

Consulting and audit

 

356 501

 

384 690

Bank charges

 

1 078

 

16 076

Other expenses

 

952 317

 

1 138 159

 

 

2 922 658

 

3 411 250

2.6 Tax expenses

Tax expenses comprise the following (in CHF):

 

 

2020

 

2019

Income taxes

 

75 442

 

32 000

Capital taxes

 

36 995

 

91 687

 

 

112 437

 

123 687

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience.Use of cookies & disclaimer